BMJ Best Practice

参考文献

关键文献

Heymann DL, Aylward RB. Eradicating polio. N Engl J Med. 2004;351:1275-1277.

Howard RS. Poliomyelitis and the postpolio syndrome. BMJ. 2005;330:1314-1318.

Farbu E, Gilhus NE, Barnes MP, et al. Post-polio syndrome: EFNS guidelines on post-polio syndrome. In: Gilhus NE, Barnes MP, Brainin M, eds. European Handbook of Neurological Management, Volume 1. 2nd ed. West Sussex, UK: Blackwell Publishing Ltd.; 2011:311-319.

参考文章

1.  Heymann DL, Aylward RB. Eradicating polio. N Engl J Med. 2004;351:1275-1277.

2.  Cochi SL, Kew O. Polio today: are we on the verge of global eradication? JAMA. 2008;300:839-841.

3.  Global Polio Eradication Initiative. The vaccines. [internet publication].

4.  el-Sayed N, el-Gamal Y, Abbassy AA, et al. Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med. 2008;359:1655-1665.

5.  Centers for Disease Control and Prevention (CDC). International notes certification of poliomyelitis eradication - the Americas, 1994. MMWR Morb Mortal Wkly Rep. 1994;43:720-722.

6.  Centers for Disease Control and Prevention (CDC). Poliovirus infections in four unvaccinated children-Minnesota, August-October 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1053-1055.

7.  Global Polio Eradication Initiative. This week. April 2018 [internet publication].

8.  World Health Organization. Statement of the Sixteenth IHR Emergency Committee Regarding the International Spread of Poliovirus. February 2018 [internet publication].

9.  Lahariya C, Pradhan SK. Prospects of eradicating poliomyelitis by 2007: compulsory vaccination may be a strategy. Indian J Pediatr. 2007;74:61-63.

10.  American Academy of Pediatrics. Poliovirus infections. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:541-545.

11.  Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J. 1999;18:1033-1039.

12.  Heymann D, Aylward B. Polio will soon be history. Bull World Health Organ. 2007;85:7-8.

13.  Aylward RB. Eradicating polio: today's challenges and tomorrow's legacy. Ann Trop Med Parasitol. 2006;100:401-413.

14.  Aylward RB, Acharya A, England S. Global health goals: Lessons from the worldwide effort to eradicate poliomyelitis. Lancet. 2003 362:909-914.

15.  Cuba IPV Study Collaborative Group. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med. 2007;356:1536-1544.

16.  Guerra FA, Blatter MM, Greenberg DP, et al; Pentacel Study Group. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Pediatrics. 2009;123:301-312.

17.  Robinson CL, Bernstein H, Romero JR, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):112-114.

18.  Klein NP, Weston WM, Kuriyakose S, et al. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children. Vaccine. 2012;30:668-674.

19.  Bernstein HH, Noriega F; M5A07 Pentacel Study Group. Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when administered concurrently with a pneumococcal conjugate vaccine: a randomized, open-label, phase 3 study. Vaccine. 2011;29:2212-2221.

20.  Centers for Disease Control and Prevention. General best practice guidelines for immunization: altered immunocompetence. Best practice guidance of the Advisory Committee on Immunization Practices (ACIP). Sep 2018 [internet publication].

21.  World Health Organization. Polio Global Eradication Initiative: polio eradication & endgame strategic plan, 2013-2018. 2013. http://www.polioeradication.org/ (last accessed 27 February 2017).

22.  Khan OA. Polio and post-polio syndrome. In: Zhang Y, ed. Encyclopedia of global health.Thousand Oaks, CA: Sage; 2008.

23.  Ramaraj R. Post-poliomyelitis syndrome: clinical features and management. Br J Hosp Med. 2007;68:648-650.

24.  Howard RS. Poliomyelitis and the postpolio syndrome. BMJ. 2005;330:1314-1318.

25.  Neumann DA. Polio: its impact on the people of the United States and the emerging profession of physical therapy. J Orthop Sports Phys Ther. 2004;34:479-492.

26.  Miller AH, Buck LS. Tracheotomy in bulbar poliomyelitis. Calif Med. 1950;72:34-36.

27.  Bruno RL. Post-polio syndrome. Neurology. 1996;47:1359-1360.

28.  Farbu E, Gilhus NE, Barnes MP, et al. Post-polio syndrome: EFNS guidelines on post-polio syndrome. In: Gilhus NE, Barnes MP, Brainin M, eds. European Handbook of Neurological Management, Volume 1. 2nd ed. West Sussex, UK: Blackwell Publishing Ltd.; 2011:311-319.

29.  Koopman FS, Beelan A, Gilhus NE, et al. Treatment for postpolio syndrome. Cochrane Database Syst Rev. 2015;(5):CD007818.

30.  Hammon WM, Coriell LL, Ludwig EH, et al. Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory-confirmed cases. J Am Med Assoc. 1954;156:21-27.

使用此内容应接受我们的免责声明。